A Study in Participants With Type 1 Diabetes Mellitus

NCT01481779 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

455

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Glargine
DRUG: LY2605541
DRUG: Insulin Lispro

Sponsor

Eli Lilly and Company